Literature DB >> 22008727

Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Taiwanese patients with Type 2 diabetic mellitus.

Yih-Hsin Chang1, Wen-Mei Fu, Yu-Hui Wu, Chih-Jung Yeh, Chien-Ning Huang, Ming-Yuh Shiau.   

Abstract

OBJECTIVES: Deficiency and/or decreased activity of methyltetrahydrofolate reductase (MTHFR) resulted from MTHFR variants are associated with hyperhomocysteinemia, an independent risk factor for vasculopathies in diabetic patients. The aim of this study was to examine MTHFR genotypes between healthy and type 2 diabetes mellitus (T2DM) subjects. DESIGN AND METHODS: MTHFR C677T and A1298C genotypes were analyzed in 56 T2DM and 62 healthy subjects by PCR-RFLP. Association between MTHFR genotypes and T2DM as well as the lipid/glucose metabolic indexes among T2DM subjects was statistically analyzed.
RESULTS: No significance in the distribution of MTHFR genotypes between healthy and T2DM subjects is found. Besides, no significant associations between lipid/glucose metabolic indexes with MTHFR genotypes among diabetic patients are observed.
CONCLUSIONS: These data indicate the previous observation that MTHFR polymorphisms may play some roles in the pathogenesis and complications of T2DM in Caucasians are unlikely to be applied in Taiwanese patients.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008727     DOI: 10.1016/j.clinbiochem.2011.09.020

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Na-Na Yang; Le-Qun Li
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

2.  Additive Interaction of MTHFR C677T and MTRR A66G Polymorphisms with Being Overweight/Obesity on the Risk of Type 2 Diabetes.

Authors:  Xueyuan Zhi; Boyi Yang; Shujun Fan; Yongfang Li; Miao He; Da Wang; Yanxun Wang; Jian Wei; Quanmei Zheng; Guifan Sun
Journal:  Int J Environ Res Public Health       Date:  2016-12-15       Impact factor: 3.390

3.  Association of Kaphaja and Kapha-Pittaja Prakriti and methylenetetrahydrofolate reductase C677T allele with type 2 diabetes.

Authors:  Archana Gupta; Akhtar Ali; Priyadarshini Tewari; Neeraj Kumar Agrawal; Rashmi Patel; Parameswarappa Shivappa Byadgi
Journal:  Ayu       Date:  2018 Jul-Sep

4.  Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.

Authors:  Zhong Lin; Qianxi Li; Yifan Sun; Jingchun Huang; Wan Wang; Jinjian Fu; Jianhua Xu; Dingyuan Zeng
Journal:  Lipids Health Dis       Date:  2019-06-15       Impact factor: 3.876

5.  Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years.

Authors:  Xianhui Qin; Jianping Li; Yan Zhang; Wei Ma; Fangfang Fan; Binyan Wang; Houxun Xing; Genfu Tang; Xiaobin Wang; Xin Xu; Xiping Xu; Yong Huo
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.

Authors:  Wen-Xing Li; Wen-Wen Lv; Shao-Xing Dai; Ming-Luo Pan; Jing-Fei Huang
Journal:  Lipids Health Dis       Date:  2015-09-04       Impact factor: 3.876

7.  Association of tagging SNPs in the MTHFR gene with risk of type 2 diabetes mellitus and serum homocysteine levels in a Chinese population.

Authors:  Han Wang; Cong Hu; Shu-Hui Xiao; Bin Wan
Journal:  Dis Markers       Date:  2014-08-06       Impact factor: 3.434

8.  Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.

Authors:  Yanzi Meng; Xiaoling Liu; Kai Ma; Lili Zhang; Mao Lu; Minsu Zhao; Min-Xin Guan; Guijun Qin
Journal:  Mol Genet Genomic Med       Date:  2019-10-30       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.